Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

ALLERGAN, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Latest news on ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
RE
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
PU
2017U.S. state, local government lawsuits over opioids face uphill battle
RE
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
PU
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
PU
2017ALLERGAN : Eyepowerment™ Campaign Releases Survey Revealing the Importance..
PU
2017Several top fund managers trim Allergan stakes in first quarter
RE
2017CARL ICAHN : Icahn takes new 19.8 million share stake in Conduent in first quart..
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017High-profile Snap stakeholders revealed in filings
RE
2017ALLERGAN, INC. : Today's Research Reports on Stocks to Watch: Allergan and Celge..
AC
2017Allergan posts loss as it writes down Teva holdings
RE
2017Allergan posts loss as it writes down Teva holdings
RE
2017Sanofi pegs U.S. drug price rises to below healthcare inflation
RE
2017ALLERGAN : to Present New Data at the 2017 American College of Obstetricians and..
PU
2017ALLERGAN : and Ironwood Launch Campaign Designed to Empower the Nearly 64 Millio..
PU
2017ALLERGAN : Launches Frames of Mind, Encouraging People Living with Migraine to S..
PU
2017ALLERGAN : Teams Up With Media Mogul Wendy Williams to Debut the Patient Empower..
PU
2017ALLERGAN, INC. : Blog Coverage Allergan and Paratek's Acne Drug Reported Positiv..
AC
2017ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
PU
2017ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
PU
2017ALLERGAN : New Survey Reveals Impact Of Double Chin On Self-Perception And Behav..
PU
2017ALLERGAN : New Eyepowerment™ Campaign Urges The Up To 33 Million Americans..
PU
2017Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
RE
2017ALLERGAN, INC. : Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence ..
AC
2017Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
RE
2017Stada to hold takeover talks with rival suitors Cinven and Advent
RE
2017Allergan says U.S. tax reform unlikely in 2017, sees strong year
RE
2017ALLERGAN : Launches See America(SM), a Bold Initiative Furthering the Fight Agai..
PU
2017ALLERGAN : Launches Juvéderm® Volite - an Innovative Injectable Treatment Design..
PU
2017ALLERGAN : U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (l..
PU
2017U.S. reaches settlement with Endo on pay-for-delay charges
RE
2017ALLERGAN : Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride..
PU
2017Allergan to pay $15 million over failing to disclose merger talks
RE
2017ALLERGAN : and Gedeon Richter Announce Positive Phase III Results for Ulipristal..
PU
2017Pharma company executives debate drug pricing increases
RE
2017ABRAHAM, FRUCHTER & TWERSKY, LLP FIL : Agn)
MW
2017ALLERGAN, INC. : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Inv..
AC
2016ALLERGAN, INC. : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses I..
AC
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses i..
AC
2016Actavis UK raised drug prices 12,000 percent, watchdog finds
RE
2016U.S. states sue Mylan, Teva, others for fixing drug prices
RE
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
AC
2016ALLERGAN, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
AC
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016ALLERGAN, INC. : Pomerantz Law Firm Reminds Shareholders with Losses on their In..
AC
2016Pharma execs weigh in on possible changes under Trump
RE
2016ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
AC
2016Lilly's drug for Alzheimer's fails big trial; shares drop
RE
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
AC
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class ..
AC
2016ALLERGAN : Announces Partnership with Amy Dixon, Elite Paratriathlete, to Improv..
PU
2016Teva trims 2016 outlook on drug launch delays
RE
2016ALLERGAN, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
AC
2016ALLERGAN, INC. : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
AC
2016ALLERGAN, INC. : Lundin Law PC Announces Securities Class Action Lawsuit against..
AC
2016ALLERGAN : Announces Launch of TAYTULLA™ (Norethindrone Acetate and Ethiny..
PU
2016ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Announces Investigation of A..
AC
2016Drugmakers under fire for possible U.S. price fixing
RE
2016Allergan CEO takes blame for big miss on quarterly earnings
RE
2016U.S. HOT STOCKS : Hot Stocks to Watch
DJ
2016ALLERGAN : Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsio..
PU
2016ALLERGAN : Announces Changes to Board Leadership
PU
2016ALLERGAN : JUVÉDERM VOLBELLA® XC Now Available To Doctors And Patients In The U...
PU
2016ALLERGAN : Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) wit..
PU
2016ALLERGAN : Demonstrates Continued Commitment to Irritable Bowel Syndrome with Di..
PU
2016U.S. targets corporate tax-reduction strategy with new regulation
RE
2016Pfizer Loses UK Appeal Court Patent Case Over Lyrica
DJ
2016Teva to sell Allergan's generics business in UK, Ireland for $769 million
RE
2016AstraZeneca licenses respiratory drug to Insmed
RE
2016ALLERGAN : Acquires Akarna Therapeutics Adding to its Strong Development Program..
PU
1  2  3  4  5  6  7  8  9  10Next
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
Cathy Taylor Media Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON-12.27%327 330
PFIZER0.00%213 275
NOVARTIS-10.87%189 575
ROCHE HOLDING LTD.-12.58%188 417
MERCK AND COMPANY8.90%164 862